Expert Recap

CCO Expert Recap: HCV Treatment Update

Source: Advances in HCV Treatment: 2006*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

CCO Expert Recap: HCV Treatment Update


Faculty:

  • Mitchell L. Shiffman, MD

CME CREDIT INFORMATION

Release Date: 12/12/06

Expiration Date: 12/11/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the clinical implications of new diagnostic tools in choosing when to initiate HCV therapy
  • Recount clinical trial data from studies evaluating the management of difficult-to-treat patient cohorts with chronic hepatitis C
  • Describe the clinical implications of new therapies on the management of patients with chronic hepatitis C

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.

Related Content

Related Tracks from this CCO Independent Conference Coverage:


Clinical Updates in HBV Treatment